   "); bodyStart = html.indexOf("
   ") + 10; bodyEnding = html.indexOf(""); if (titleStart > 0 && titleEnd
   > 0 && urlStart > 0 && urlEnd > 0 && nameStart > 0 && nameEnding > 0 &&
   bodyStart > 0 && bodyEnding > 0) { //title = html.substring(titleStart,
   titleEnd); title = html.substring(nameStart, nameEnding); bodyTxt =
   html.substring(bodyStart, bodyEnding).toString(); bodyTxt =
   bodyTxt.replace(regex1, ""); bodyTxt = bodyTxt.replace(regex2, ""); url
   = html.substring(urlStart, urlEnd);
   //document.getElementById("entitle").innerHTML = title + "
   Read More"; document.getElementById("entitle").innerHTML = "

   "+"

   " + bodyTxt + "

   " + "

   Read More

   " + "

   Click to close

   "; var container2012 = $( "#container2012" ); container2012.slideDown(
   1000 ); } setTimeout(checkEmergencyNotification, 60000); } function
   closewindow() { jQuery(function( $ ) { $.cookie("notified", true, {
   path: "/" }, { expires: 1 }); // Get a reference to the container var
   container2012 = $( "#container2012" ); container2012.slideUp( 1000 );
   }); } window.onload = function() { checkEmergencyNotification(); };

   Print Profile Print Profile

   emily.bernstein@mssm.edu

   Ph.D., SUNY Stony Brook/Cold Spring Harbor Laboratory

   The Rockefeller University

   2012 - 2016
   Irma T. Hirschl Charitable Trust Research Award

   2010 - 2011
   Tisch Cancer Institute Developmental Fund Award
   Mount Sinai School of Medicine

   2008 - 2012
   New Scholar Award
   Ellison Medical Foundation

   2008 - 2009
   Research Scholar Award
   American Skin Association

   2004 - 2006
   National Science Foundation Postdoctoral Fellowship

   Duarte LF, Young AR, Wang Z, Wu HA, Panda T, Kou Y, Kapoor A, Hasson D,
   Mills NR, Ma'ayan A, Narita M, Bernstein E. Histone H3.3 and its
   proteolytically processed form drive a cellular senescence programme.
   Nature communications 2014; 5.

   Wu HA, Balsbaugh JL, Chandler H, Georgilis A, Zullow H, Shabanowitz J,
   Hunt DF, Gil J, Peters G, Bernstein E. Mitogen-activated protein kinase
   signaling mediates phosphorylation of polycomb ortholog Cbx7. The
   Journal of biological chemistry 2013 Dec; 288(51).

   Vardabasso C, Hasson D, Ratnakumar K, Chung CY, Duarte LF, Bernstein E.
   Histone variants: emerging players in cancer biology. Cellular and
   molecular life sciences : CMLS 2013 May;.

   Gaspar-Maia A, Qadeer ZA, Hasson D, Ratnakumar K, Adrian Leu N, Leroy
   G, Liu S, Costanzi C, Valle-Garcia D, Schaniel C, Lemischka I, Garcia
   B, Pehrson JR, Bernstein E. MacroH2A histone variants act as a barrier
   upon reprogramming towards pluripotency. Nature communications 2013
   Mar; 4.

   Ratnakumar K, Duarte LF, Leroy G, Hasson D, Smeets D, Vardabasso C,
   Bönisch C, Zeng T, Xiang B, Zhang DY, Li H, Wang X, Hake SB,
   Schermelleh L, Garcia BA, Bernstein E. ATRX-mediated chromatin
   association of histone variant macroH2A1 regulates α-globin
   expression. Genes & development 2012; 26: 433-438.

   Chicas A, Kapoor A, Wang X, Aksoy O, Evertts AG, Zhang MQ, Garcia BA,
   Bernstein E, Lowe SW. H3K4 demethylation by Jarid1a and Jarid1b
   contributes to retinoblastoma-mediated gene silencing during cellular
   senescence. Proceedings of the National Academy of Sciences of the
   United States of America 2012 Jun; 109(23).

   O'Loghlen A, Muñoz-Cabello AM, Gaspar-Maia A, Wu HA, Banito A,
   Kunowska N, Racek T, Pemberton HN, Beolchi P, Lavial F, Masui O,
   Vermeulen M, Carroll T, Graumann J, Heard E, Dillon N, Azuara V,
   Snijders AP, Peters G, Bernstein E, Gil J. MicroRNA regulation of Cbx7
   mediates a switch of Polycomb orthologs during ESC differentiation.
   Cell stem cell 2012 Jan; 10(1).

   Kapoor A, Goldberg M, Cumberland L, Ratnakumar K, Segura M, Emanuel P,
   Menendez S, Vardabasso C, LeRoy G, Vidal C, Polsky D, Osman I, Garcia
   B, Hernando E, Bernstein E. The histone variant macroH2A suppresses
   melanoma progression through regulation of CDK8. Nature 2010; 468:
   1105-1109.

   Bernstein E, Muratore-Schroeder TL, Diaz RL, Chow JC, Changolkar LN,
   Shabanowitz J, Heard E, Pehrson JR, Hunt DF, Allis CD. A phosphorylated
   subpopulation of the histone variant macroH2A1 is excluded from the
   inactive X chromosome and enriched during mitosis. Proc Natl Acad Sci
   USA 2008; 105: 1533-1538.

   Whitcomb SJ, Basu A, Allis CD, Bernstein E. Polycomb Group Proteins: an
   evolutionary perspective. Trends in Genetics 2007; 23: 494-502.

   Ooi S, Qiu C, Bernstein E, Li K, Dia D, Yang Z, Erdjument-Bromage H,
   Tempst P, Lin S, Allis CD, Cheng X, Bestor TH. DNMT3L connects
   unmethylated lysine 4 of histone H3 to de novo methylation of DNA.
   Nature 2007; 448: 714-717.

   Goldberg AD, Allis CD, Bernstein E. Epigenetics: a landscape takes
   shape.. Cell (essay) 2007; 128: 635-638.

   Bernstein E, Duncan EM, Masui O, Gil J, Heard E, Allis CD. Mouse
   Polycomb proteins bind differentially to methylated histone H3 and RNA
   and are enriched in facultative heterochromatin. Molecular and Cellular
   Biology 2006; 26: 2560-2569.

   Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, Li MZ, Mills
   AA, Elledge SJ, Anderson KV, Hannon GJ. Dicer is essential for mouse
   development. Nature Genetics 2003; 35: 5215-5217.

   Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, Conklin DS. Short
   hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian
   cells. Genes & Development 2002; 16: 948-958.

   Ketting RF, Fischer SJ, Bernstein E, Sijen T, Hannon GJ, Plasterk RA.
   Dicer functions in RNA interference and in synthesis of small RNA
   involved in developmental timing in C. elegans. Genes & Development;
   15: 2654-2695.

   Bernstein E, Caudy AA, Hammond SM, Hannon GJ. Role for a bidentate
   nuclease in the initiation step of RNA interference. Nature 2001; 409:
   363-366.

   Hammond SM, Bernstein E, Beach D, Hannon GJ. An RNA-directed nuclease
   mediates post-transcriptional gene silencing in Drosophila cells.
   Nature 2000; 404: 293-296.

   Physicians and scientists on the faculty of the Icahn School of
   Medicine at Mount Sinai often interact with pharmaceutical, device and
   biotechnology companies to improve patient care, develop new therapies
   and achieve scientific breakthroughs. In order to promote an ethical
   and transparent environment for conducting research, providing clinical
   care and teaching, Mount Sinai requires that salaried faculty inform
   the School of their relationships with such companies.

   Dr. Bernstein did not report having any of the following types of
   financial relationships with industry during 2014 and/or 2015:
   consulting, scientific advisory board, industry-sponsored lectures,
   service on Board of Directors, participation on industry-sponsored
   committees, equity ownership valued at greater than 5% of a publicly
   traded company or any value in a privately held company. Please note
   that this information may differ from information posted on corporate
   sites due to timing or classification differences.

   Mount Sinai's faculty policies relating to faculty collaboration with
   industry are posted on our website. Patients may wish to ask their
   physician about the activities they perform for companies.

   Edit profile in Sinai Central

   Hess CSM Building Floor 6th floor Room room 114
   1470 Madison Avenue
   New York, NY 10029
file:///var/folders/07/q1dxpd8s56s0tfqh7n6xv3rm0000gn/T/"%20+%20url%20+%20"
file:///var/folders/07/q1dxpd8s56s0tfqh7n6xv3rm0000gn/T/"%20+%20url%20+%20"
file:///var/folders/07/q1dxpd8s56s0tfqh7n6xv3rm0000gn/T/L49562-3885TMP.html
javascript:window.print()
mailto:emily.bernstein@mssm.edu
http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook
http://sinaicentral.mssm.edu/
